
Maryland Venture Fund
Columbia, Maryland, United StatesFounded 1995
The Maryland Venture Fund is an evergreen, state-backed venture capital fund managed by TEDCO (Maryland Technology Development Corporation) that invests in early-stage technology and life sciences companies connected to Maryland. Originally organized as the Investment Financing Group in 1995, it was transferred to TEDCO in October 2015.
Their most common stage is series-a (53% of deals). Average disclosed round size is $11.2M (across 15 rounds with reported amounts).
Portfolio
16
Fund Size
$110M
Top Stage
Series A
Last 12 Mo
0
Team
AJ
Andy Jones
Managing Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
17 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAttila Security | Series A | $750K | Jan 2020 |
| RRackTop | Series A | $15M | Jan 2019 |
| Series A | $36M | Jul 2018 | |
| Seed | $6M | May 2018 | |
| PPersonal Genome Diagnostics (PGDx) | Series B | — | Jan 2018 |
| Series B | — | Jan 2018 | |
| Series B | $20M | Jan 2017 | |
| Series D | $41M | Jan 2017 | |
| TTales2Go | Unknown | $2.4M | Mar 2015 |
| HHarpoon Medical, Inc. | Series A | $3.2M | Jan 2015 |
| HHarpoon Medical, Inc. | Series A | $3.8M | Sep 2014 |
| CCitelighter | Seed | $1.5M | Jan 2014 |
| 4410 Labs | Series A | $750K | — |
| Unknown | $11M | — | |
| Series A | $3.4M | — | |
| SSalsa Software | Series A | $20M | — |
| Series A | $3.5M | — |
Top Co-Investors
New Enterprise Associates3 shared
Grotech Ventures2 shared
Bristol Myers Squibb2 shared
Windham Capital Partners2 shared
Epidarex Capital2 shared
Great Road Holdings2 shared
Venrock1 shared
GV1 shared
ARCH Venture Partners1 shared
Primary Venture Partners1 shared
Biomatics Capital1 shared
Telcom Ventures1 shared
Adelie Capital1 shared
500 Global1 shared
True Ventures1 shared
Razor's Edge Ventures1 shared
Gula Tech Adventures1 shared
Northpond Ventures1 shared
Catalio Capital Management1 shared
3TS Capital Partners1 shared
Last updated: 7 October 2026